Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis

NCT04324918 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Perennial Allergic Rhinitis

Interventions

DRUG: HCP1102
DRUG: HGP1408

Sponsor

Hanmi Pharmaceutical Company Limited